The cholinergic hypothesis emphasizes the deficit of neurotransmitter acetylcholine (ACh) in the brain regions of AD patients that leads to memory and cognitive impairments and supports that a decrease in the ACh hydrolysis by inhibiting acetylcholinesterase (AChE) can alleviate these symptoms [3,4,5,6,7]. Here, ACHE is linked to Alzheimer disease.